News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Tissue Regeneration Therapeutics Inc. Announces $20 M Stem Cell License to Stem Cell Authority Ltd. for US Market


6/21/2007 10:35:20 AM

TORONTO, ONTARIO--(MARKET WIRE)--Jun 21, 2007 -- Tissue Regeneration Therapeutics Inc. (TRT) announced today the exclusive US license of its HUCPVC (human umbilical cord perivascular cell) technology to Stem Cell Authority Ltd. (SCAL) for family stem cell banking. Under the terms of the agreement, SCAL gains US patent rights and manufacturing know-how in return for an upfront technology access fee and annual minimum royalties that will exceed CAD $20 M over the next four years. SCAL is currently offering HUCPVC collection and storage services to physicians for their patients across the US.

Read at press release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES